Transformation of liver by SV-40 T-antigen in transgenic mice is unaffected by metallothionein

Cancer Letters

Volumn 106, Issue 1, 1996, Pages 125-131

  Quaife, Carol J ^a   Veith, Gregory C ^a   Palmiter, Richard D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Liver; Metallothionein; P53; Retinoblastoma; SV 40 T antigen; Tumorigenesis

Indexed keywords

ALANINE AMINOTRANSFERASE; METALLOTHIONEIN; PROTEIN P53; SERINE; VIRUS T ANTIGEN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0030599031     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04316-9     Document Type: Article

References (31)

1. [1] Vogelstein, B. and Kinzler, K.W. (1993) The multistep nature of cancer. Trends Genet., 4, 138-141.
2. [2] Weinberg, R.A. (1995) The molecular basis of oncogenes and tumor suppressor genes. Ann. N. Y. Acad. Sci., 758, 331-338.
3. [3] Viney, J.L. (1995) Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev., 14, 77-90.
4. [4] Sandgren, E.P., Quaife, C.J., Pinkert, C.A., Palmiter, R.D. and Brinster, R.L. (1989) Oncogene-induced liver neoplasia in transgenic mice. Oncogene, 4, 715-724.
5. [5] Livingston, D.M. (1992) Functional analysis of the retinoblastoma gene product and of RB-SV40 T antigen complexes. Cancer Surv., 12, 153-160.
6. [6] Ludlow, J.W. (1993) Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J., 7, 866-871.
7. [7] Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
8. [8] Cherian, M.G., Howell, S.B., Imura, N., Klaassen, C.D., Koropatnick, J., Lazo, J.S. and Waalkes, M.P. (1994) Contemporary issues in toxicology: role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol., 126, 1-5.
9. [9] Ebadi, M. and Swanson, S. (1988) The status of zinc, copper and metallothionein in cancer patients. Prog. Clin. Biol. Res., 259, 161-175.
10. [10] Suzuki, K.T., Imura, N. and Kimura, M. (Eds.) (1993) Metallothionein III: Biological Roles and Medical Implications. Birkhäuser Verlag, Basel, Switzerland.
11. [11] Ebadi, M. and Iversen, P.L. (1994) Metallothionein in carcinogenesis and cancer chemotherapy. Gen. Pharmacol., 25, 1297-1310.
12. [12] Michalska, A.E. and Choo, A.K.H. (1993) Targeted and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA, 90, 8088-8092.
13. [13] Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L. and Palmiter, R.D. (1994) Targeted disruption of metallothionein I and II genes increases sensitivity of cadmium. Proc. Natl. Acad. Sci. USA, 91, 584-588.
14. [14] Ouellette, A.J. (1982) Metallothionein mRNA expression in fetal mouse organs. Dev. Biol., 92, 240-246.
15. [15] Andrews, G.K., Adamson, E.D. and Gedamu, L. (1984) The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. Dev. Biol., 103, 294-303.
16. [16] Quaife, C., Hammer, R.E., Mottet, N.K. and Palmiter, R.D. (1986) Glucocorticoid regulation of metallothionein during murine development. Dev. Biol., 118, 549-555.
17. [17] Tsujikawa, K., Suzuki, N., Sagawa, K., Itoh, M., Sugiyama, T., Kohama, Y., Otaki, N., Kimura, M. and Mimura, T. (1994) Induction and subcellular localization of metallothionein in regenerating rat liver. Eur. J. Cell Biol., 63, 240-246.
18. [18] Cherian, G.M. (1994) The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect., 102 (Suppl. 3), 131-135.
19. [19] Nagel, W.W. and Vallee, B.L. (1995) Cell cycle regulation of metallothionein in human colonic cancer cells. Proc. Natl. Acad. Sci. USA, 92, 579-83.
20. [20] Palmiter, R.D., Findley, S.S., Whitmore, T.E. and Durnam, D.M. (1992) MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA, 89, 6333-6337.
21. [21] Palmiter, R.D., Sandgren, E.P., Koaller, D.M., Findley, S.D. and Brinster, R.L. (1993) Metallothionein genes and their regulation in transgenic mice. In: Metallothionein III: Biological Roles and Medical Implications, pp. 399-406. Editors: K.T. Suzuki, N. Imura, and M. Kimura. Birkhäuser Verlag, Basel, Switzerland.
22. [22] Masters, B.A., Quaife, C.J., Erickson, J.C., Kelly, E.J., Froelick, G.J., Zambrowicz, B.P., Brinster, R.L. and Palmiter, R.D. (1994) Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci., 14, 5844-5877.
23. [23] Quaife, D.J., Findley, S.D., Erickson, J.C., Froelick, G.J., Kelly, E.J., Zambrowicz, B.P. and Palmiter, R.D. (1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry, 33, 7250-7259.
24. [24] Palmiter, R.D., Sandgren, E.P., Koeller, D.M. and Brinster, R.L. (1993) Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol., 13, 5266-5275.
25. [25] Iszard, M.B., Liu, J., Liu, Y., Dalton, T., Andrews, G.K., Palmiter, R.D. and Klaassen, C.D. (1995) Characterization of metallothionein-I-transgenic mice. Toxicol. Appl. Pharmacol., 133, 305-312.
26. [26] Liu, Y., Liu, J., Iszard, M.B., Andrews, G.K., Palmiter, R.D. and Klaassen, C.D. (1995) Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity. Toxicol. Appl. Pharmacol., 135, 222-228.
27. [27] Chen, R.W. and Ganter, H.E. (1975) Relative cadmium binding capacity of metallothionein and other cytosolic fractions in various tissues of the rat. Environ. Physiol. Biochem., 5, 378-388.
28. [28] Kotsonis, F.N. and Klaassen, C.D. (1977) Comparison of methods for estimating hepatic metallothionein in rats. Toxicol. Appl. Pharmacol., 42, 583-588.
29. [29] Bergmeyer, H.U. and Horder, M. (1980) IFCC method for alanine aminotransferase. J. Clin. Chem. Clin. Biochem., 18, 521-534.
30. [30] Chisari, F.V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H.A., Sell, S., Pinkert, C.A., Brinster, R.L. and Palmiter, R.D. (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell, 59, 1145-1156.
31. [31] Everett, R.M. and Harrison, Jr., S.D. (1983) Clinical biochemistry. In: The Mouse in Biomedical Research, Vol. III, pp. 312-326. Editors: H.L. Foster, J.D. Small and J.G. Fox. Academic Press, New York.